Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development

Journal of Internal Medicine
P GhataorheM R Wilkins

Abstract

Pulmonary arterial hypertension (PAH), at one time a largely overlooked disease, is now the subject of intense study in many academic and biotech groups. The availability of new treatments has increased awareness of the condition. This in turn has driven a change in the demographics of PAH, with an increase in the mean age at diagnosis. The diagnosis of PAH in more elderly patients has highlighted the need for careful phenotyping of patients and for further studies to understand how best to manage pulmonary hypertension associated with, for example, left heart disease. The breadth and depth of expertise focused on unravelling the molecular pathology of PAH has yielded novel insights, including the role of growth factors, inflammation and metabolic remodelling. The description of the genetic architecture of PAH is accelerating in parallel, with novel variants, such as those reported in potassium two-pore domain channel subfamily K member 3 (KCNK3), adding to the list of more established mutations in genes associated with bone morphogenetic protein receptor type 2 (BMPR2) signalling. These insights have supported a paradigm shift in treatment strategies away from simply addressing the imbalance of vasoactive mediators observed in...Continue Reading

References

Aug 1, 1987·Annals of Internal Medicine·S RichS K Koerner
Sep 1, 1995·The American Journal of Medicine·P HervéL Drouet
Sep 6, 2000·Nature Genetics·UNKNOWN International PPH ConsortiumR C Trembath
Mar 30, 2002·Journal of the American College of Cardiology·Ronald J RaymondWalker Long
Sep 3, 2002·Journal of the American College of Cardiology·Olivier SitbonGérald Simonneau
Sep 10, 2003·The Journal of Cell Biology·Victoria C FolettaJuliana Soosairaiah
Jun 15, 2004·Journal of the American College of Cardiology·John H NewmanGregory Elliott
Oct 2, 2004·The New England Journal of Medicine·Marc HumbertGérald Simonneau
Feb 3, 2005·The European Respiratory Journal·V V McLaughlinL J Rubin
Apr 14, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Soni PullamsettiRalph Theo Schermuly
Sep 30, 2005·The New England Journal of Medicine·Hossein A GhofraniFriedrich Grimminger
Oct 25, 2006·Circulation·Norbert F VoelkelUNKNOWN National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure
Jul 21, 2007·American Journal of Respiratory and Critical Care Medicine·Micheala A AldredRichard C Trembath
Jun 17, 2008·American Journal of Respiratory and Critical Care Medicine·Pradeep R RaiNorbert F Voelkel
Apr 4, 2009·Journal of the American College of Cardiology·Rozenn QuarckMarion Delcroix
Jul 9, 2009·Journal of the American College of Cardiology·Rajiv D MachadoWendy K Chung
Aug 15, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Christophe GuignabertSaadia Eddahibi
Jan 6, 2010·Circulation·Aldons J Lusis, James N Weiss
Apr 24, 2010·BMC Pulmonary Medicine·Yasuko TakedaGenjiro Kimura
Jun 29, 2010·American Journal of Respiratory and Critical Care Medicine·Hossein A GhofraniSteve Pascoe
Jul 6, 2010·European Heart Journal·Philipp KümpersMarius M Hoeper
Dec 18, 2010·Nature Reviews. Genetics·Albert-László BarabásiJoseph Loscalzo
Mar 19, 2011·Cell·Marc VidalAlbert-László Barabási
Sep 20, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Rochus K VoellerMarc R Moon
Nov 24, 2011·American Journal of Respiratory and Critical Care Medicine·Frédéric PerrosBart N Lambrecht
Dec 3, 2011·Journal of the American College of Cardiology·Mariëlle C van de VeerdonkAnton Vonk-Noordegraaf
Mar 31, 2012·International Journal of Cardiology·Jonathan D RichStephen L Archer
Apr 3, 2012·The European Respiratory Journal·J-L Cracowski

❮ Previous
Next ❯

Citations

Jun 20, 2018·The Journal of Physiology·Cheng-Jun HuKurt R Stenmark
Aug 17, 2018·Nature Reviews. Rheumatology·Christopher P DentonJohn G Coghlan
Jun 18, 2019·Basic & Clinical Pharmacology & Toxicology·Anne Kathrine ToxvigMarcus Krüger
Oct 30, 2019·Integrated Environmental Assessment and Management·Ralph G StahlChristopher S Waldron
Dec 19, 2018·American Journal of Respiratory Cell and Molecular Biology·Robert S StearmanMark W Geraci
Apr 2, 2020·Science Advances·Qianru JinLewis H Romer
Feb 9, 2020·British Journal of Pharmacology·Natascha SommerDavid G Kiely
Jul 22, 2020·The Journal of Thoracic and Cardiovascular Surgery·Andrew F Feczko, Siva Raja
May 4, 2020·The Journal of Thoracic and Cardiovascular Surgery·Haoran MiaoYiqian Zhang
Jun 20, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yicheng YangChangming Xiong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

European Respiratory Review : an Official Journal of the European Respiratory Society
M R Wilkins
Circulation Research
Eric D Austin, James E Loyd
American Journal of Respiratory and Critical Care Medicine
Benjamin SztrymfMarc Humbert
© 2022 Meta ULC. All rights reserved